Ignite Creation Date:
2024-05-06 @ 2:45 AM
Last Modification Date:
2024-10-26 @ 11:23 AM
Study NCT ID:
NCT02126735
Status:
COMPLETED
Last Update Posted:
2016-12-30
First Post:
2013-10-14
Brief Title:
Metabolic and Cardiovascular Impact of CD36 Deficiency in African Americans
Sponsor:
Vanderbilt University Medical Center
Organization:
Vanderbilt University Medical Center
Study Overview
Official Title:
Metabolic and Cardiovascular Impact of CD36 Deficiency in African Americans
Status:
COMPLETED
Status Verified Date:
2016-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
CD36 a protein that facilitates tissue uptake of fat as a common link between blood fat concentrations and metabolic disease states such as diabetes mellitus Genetic variants in the CD36 gene are more common in African Americans compared to Whites and it may confer protection against metabolic diseases by altering the amount of fat in the blood
The purpose of this study is to compare the levels of fat in the blood and to assess endothelial dysfunction among carriers versus non-carriers of the coding SNP rs3211938 of the CD36 gene after a high fat meal challenge
The purpose of this study is to compare the levels of fat in the blood and to assess endothelial dysfunction among carriers versus non-carriers of the coding SNP rs3211938 of the CD36 gene after a high fat meal challenge
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None